Institution profile

大阪梅田セルクリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 02E2309002 +3

Location

Prefecture
Osaka
Address
大阪市北区梅田1丁目11-4大阪駅前 第4ビル2F 34-2号室

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIINot registered

Certified committee for regenerative medicine

  • 再生医療普及協会 特定認定再生医療等委員会
  • みんなの特定認定再生医療等委員会

Public score

60.9/ 100

A · Review level
25.0 / 30
B · Technologies
18.5 / 35
C · Coverage
10.7 / 25
D · Class I / II technologies
6.7 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 60.9
Public score →100

Registered technologies (4)

Stem cells (all sources) 3
Registered technologies · Japanese originalTechnology areasPlan classification
自家脂肪組織由来幹細胞(ASC)の投与による関節治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自家培養脂肪由来幹細胞を用いた変形性膝関節症治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自家脂肪組織由来幹細胞(ASC)の投与による慢性疼痛治療Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 3
Registered technologies · Japanese originalTechnology areasPlan classification
自家脂肪組織由来幹細胞(ASC)の投与による関節治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自家培養脂肪由来幹細胞を用いた変形性膝関節症治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自家脂肪組織由来幹細胞(ASC)の投与による慢性疼痛治療Stem cells (all sources)Adipose-derived stem cellsClass II
PRP and platelet-derived 1
Registered technologies · Japanese originalTechnology areasPlan classification
多血小板血漿を用いた変形性関節症治療PRP and platelet-derivedJoints and musculoskeletalClass II
Joints and musculoskeletal 3
Registered technologies · Japanese originalTechnology areasPlan classification
自家脂肪組織由来幹細胞(ASC)の投与による関節治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
多血小板血漿を用いた変形性関節症治療PRP and platelet-derivedJoints and musculoskeletalClass II
自家培養脂肪由来幹細胞を用いた変形性膝関節症治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II

Certified committee for regenerative medicine

  • 再生医療普及協会 特定認定再生医療等委員会
  • みんなの特定認定再生医療等委員会

Public document number

  • 02E2309002
  • 02E2310001
  • 01E2407014
  • 02E2602002
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
多血小板血漿を用いた変形性関節症治療Class II再生医療普及協会 特定認定再生医療等委員会02E2309002
自家培養脂肪由来幹細胞を用いた変形性膝関節症治療Class II再生医療普及協会 特定認定再生医療等委員会02E2310001
自家脂肪組織由来幹細胞(ASC)の投与による慢性疼痛治療Class IIみんなの特定認定再生医療等委員会01E2407014
自家脂肪組織由来幹細胞(ASC)の投与による関節治療Class IIみんなの特定認定再生医療等委員会02E2602002

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor